Oregon State University is a public land-grant research university in Corvallis, Oregon. OSU offers more than 200 undergraduate-degree programs along with a variety of graduate and doctoral degrees. On-campus enrollment averages near 32,000, making it the state's largest university.

During the past decade, Oregon State University conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oregon State University" #1 sponsor was "Oregon State University" with 18 trials, followed by "National Institute on Drug Abuse (NIDA)" with 1 trials sponsored, "Oregon Research Institute" with 1 trials sponsored, "Permobil, Inc." with 1 trials sponsored and "Stanford University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oregon State University" #1 collaborator was "National Institute of Environmental Health Sciences (NIEHS)" with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Lawrence Livermore National Laboratory" with 2 trials as a collaborator, "Pacific Northwest National Laboratory" with 2 trials as a collaborator and "American Cancer Society, Inc." with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Oregon State University" are "Overweight and Obesity" (3 trials), "Sedentary Lifestyle" (3 trials), "Academic Achievement" (2 trials), "Breast Cancer" (2 trials) and "Character" (2 trials). Many other conditions were trialed in "Oregon State University" in a lesser frequency.

Most popular intervention types in "Oregon State University" are "Behavioral" (10 trials), "Drug" (5 trials), "Device" (4 trials), "Other" (4 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "[14C]-benzo[a]pyrene" (2 trials), "12 mg xanthohumol per day" (1 trials), "24 mg xanthohumol per day" (1 trials), "6 mg xanthohumol per day" (1 trials) and "Alfalfa sprouts" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oregon State University" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Oregon State University". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Oregon State University, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Oregon State University, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".